跳至主要内容
临床试验/NCT04396587
NCT04396587已完成4 期

Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone in Female Patients Before Anesthesia Induction

Peking University People's Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2020年5月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
80
试验地点
1
主要终点
Respiratory rate

研究概览

简要总结

This study aimed to investigate Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone in female patients. Methods: A total of 60 patients were randomly divided into 4 groups, with 20 patients in each group. Sufentanil(0.1μg/kg), Hydromorphone(20μg/kg), or Oxycodone(60μg/kg) ,saline(10ml)was administered before anesthesia induction. Bispectral Index (BIS), Respiratory rate(RR), other non-analgesic effects at Tb (entering room), T0 (drug administration), T1 (2min), T2 (4min), T3(6min), T4(8min), T5(10min), T6(20min) were recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • American Society of Anesthesiologists GradeⅠ-II;
  • Patients undergo low-risk elective surgery for benign diseases (including laparoscopic ovarian cyst removal, laparoscopic tubal ligation, laparoscopic tubal drainage, breast operation, thyroid operation, etc) ;
  • Aged 18-45 years;
  • Body Mass Index 18-25kg/m2, weight 40-65 kilograms;
  • Agreed to participate in the research

排除标准

  • Difficult airway;
  • upper respiratory tract infection within 2 weeks;
  • history of allergy or long-term use of propofol and opioids;
  • self-rating anxiety scale before operation indicates anxiety;
  • pregnancy or lactation.

研究组 & 干预措施

Sufentanil

Experimental

Sufentanil(0.1μg/kg)

干预措施: Sufentanil (Drug)

Hydromorphone

Experimental

Hydromorphone(20μg/kg)

干预措施: Hydromorphone (Drug)

Oxycodone

Experimental

Oxycodone(60μg/kg)

干预措施: Oxycodone (Drug)

normal saline

Placebo Comparator

10ml

干预措施: normal Saline (Drug)

结局指标

主要结局

Respiratory rate

时间窗: 20 minutes after administration

Number of breaths per minute

Bispectral Index

时间窗: 20 minutes after administration

bispectral index(BIS): assessing the sedation, placed on the patient's forehead, BIS values 0-100, and the higher score means patients are more conscious

dizziness

时间窗: 20 minutes after administration

a temporary feeling that your sense of balance is not good and that you may fall down

次要结局

  • itch(20 minutes after administration)
  • nausea or vomiting(20 minutes after administration)
  • drowsiness(20 minutes after administration)
  • sweating(20 minutes after administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanqi

Principal Investigator

Peking University People's Hospital

研究点 (1)

Loading locations...

相似试验

Non-analgesic Effects Produced by Equipotent... | 临床试验